Acute Interstitial Pneumonia
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Acute Interstitial Pneumonia

What is the definition of Acute Interstitial Pneumonia?
Acute interstitial pneumonia (AIP) is a rare and serious condition that affects the lungs. The signs and symptoms generally develop and progress rapidly. In the early stages of the condition, affected people may experience upper respiratory and/or viral-like symptoms such as cough, shortness of breath, and fever. This is followed by the rapid onset of respiratory failure and the need for mechanical ventilation in the majority of cases. The underlying cause of AIP is unknown. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Acute Interstitial Pneumonia?
  • Acute interstitial pneumonia
  • Acute interstitial pneumonitis
  • Hamman-Rich syndrome
Who are the top Acute Interstitial Pneumonia Local Doctors?
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine
Referral may be required

UPMC Comprehensive Lung Center - Simmons Center

3601 5th Avenue, Building 4, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kevin Gibson, MD, specializes in interstitial lung disease and is board-certified in pulmonary disease and internal medicine by the American Board of Internal Medicine. He practices at UPMC Comprehensive Lung Center - Simmons Center and is affiliated with University of Pittsburgh Physicians, Department of Medicine and UPMC Presbyterian. Dr. Gibson completed his medical degree at University of Medicine and Dentistry of New Jersey, residency at Emory University School of Medicine, and fellowship at the University of Pittsburgh School of Medicine.Dr. Gibson specializes in treating patients with idiopathic pulmonary fibrosis, sarcoidosis, autoimmune lung disease, and occupational lung disease. Dr. Gibson is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Gibson is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Gibson is currently accepting new patients.

Elite in Acute Interstitial Pneumonia
Intensive Care Medicine | Pulmonary Medicine
Elite in Acute Interstitial Pneumonia
Intensive Care Medicine | Pulmonary Medicine
Referral may be required

Inova Medical Group - Transplant Specialties

3300 Gallows Rd, Heart And Lung Transplant, 
Falls Church, VA 
Languages Spoken:
English, Russian
Offers Telehealth

Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Clinical Medicine at Georgetown University School of Medicine and an Associate Clinical Professor of Medicine at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. Blog Posts What is Pulmonary Hypertension? Learn the Facts to Breathe Easy (November 2018) Pulmonary Hypertension is Serious. Learn to Spot the Signs (May 2017). Dr. Shlobin is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine | Sleep Medicine
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine | Sleep Medicine
Referral may be required

Baylor College Of Medicine - Pulmonary

7200 Cambridge St, 8th Floor, Ste 8A-2, 
Houston, TX 
Languages Spoken:
English
Accepting New Patients

Ivan Rosas, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Ivan Rosas specializes in Pulmonary Disease and works at BCM - Faculty Group Practice. To make an appointment, please call (713) 798-2400. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Rosas is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Rosas is currently accepting new patients.

What are the latest Acute Interstitial Pneumonia Clinical Trials?
Imaging Signature of Progressive Pulmonary Fibrosis in Idiopathic Pulmonary Fibrosis and Non-IPF Interstitial Lung Diseases

Summary: This study is a prospective observational study for subjects with idiopathic pulmonary fibrosis (IPF) or non-IPF interstitial lung diseases (ILD). The purpose of this study is to compare whether imaging patterns from high-resolution computed tomography (HRCT) at baseline can predict worsening. Single Time point Prediction (STP) is a score derived from an artificial intelligenc/ machine learning (A...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Summary: This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in subjects with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center